What is the current analyst consensus for Oscar Health?
The consensus rating is "Hold" with an average target price of $16.58.
Yanuki
ARTICLE DETAIL
Oscar Health (OSCR) Stock: Analyst Targets Urge Caution Amidst Volatility | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026 | Oscar Health (OSCR) Stock: Analyst Targets Urge Caution Amidst Volatility | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026
Finance / Stock Market
Oscar Health (OSCR) Stock: Analyst Targets Urge Caution Amidst Volatility
Oscar Health, Inc. (OSCR) is experiencing significant stock volatility. While the company shows profitability, analyst targets suggest caution. The stock opened with a surge, followed by a sharp decline and subsequent recovery, reflecting m...
Key Insights
- Barclays initiated coverage with an "underweight" rating and a $17.00 price target, suggesting a potential downside of 16.79%.
- Other brokerages have also weighed in, with ratings ranging from "sell" to "hold."
- The consensus rating is "Hold" with an average target price of $16.58.
- Oscar Health reported $0.92 earnings per share for the quarter, beating estimates by $0.09.
- The company has a positive trailing twelve-month (TTM) EPS of $0.40.
In-Depth Analysis
Oscar Health (NYSE:OSCR) has shown resilience with a V-shaped recovery after an initial sell-off. However, the 1-year analyst target estimate of $17.49 is substantially below the current trading level. This indicates that analysts believe the stock is overvalued, despite the company’s profitability.
**Factors to consider:**
- **Bullish Momentum:** The stock’s recovery from its daily low signals buying pressure.
- **Bearish Concerns:** Analyst targets suggest the stock is overvalued, and profit-taking could lead to further declines.
- **Financial Metrics:** Oscar Health has a quick ratio and current ratio of 0.88, a debt-to-equity ratio of 0.22, and a market cap of $5.20 billion.
- **Insider Activity:** Recent sales by company directors may also influence investor sentiment.
**How to Prepare:**
- **Monitor Analyst Ratings:** Keep an eye on any changes in analyst ratings and price targets.
- **Assess Risk Tolerance:** Evaluate your risk tolerance and investment horizon before making any decisions.
- **Consider a Diversified Portfolio:** Diversify your investments to mitigate risk.
**Who This Affects Most:**
- **Short-term Traders:** Volatility offers opportunities but with elevated risk.
- **Long-term Investors:** The key question is whether future growth can justify the current valuation.
FAQ
Is Oscar Health profitable?
Yes, Oscar Health has a positive trailing twelve-month (TTM) EPS of $0.40.
What is the potential downside according to Barclays?
Barclays set a price target of $17.00, suggesting a potential downside of 16.79%.
Takeaways
- Oscar Health’s stock is experiencing significant volatility.
- Analyst targets suggest caution, despite the company’s profitability.
- Monitor analyst ratings and assess your risk tolerance before investing.
- The stock’s future growth will need to justify its current valuation.
Discussion
Do you think Oscar Health can maintain its profitability and justify its current valuation? Let us know in the comments!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.